^○Tetsuya Ioku¹, Keisuke Imai¹, Takehiro Yamada¹, Atsushi Yamamoto¹, Toshi Sai¹, Masanori Cho¹, Ryota Ueda¹, Takuma Kato¹, Takumi Ikeda² (1.Department of Neurology and Stroke Treatment, Kyoto First Red Cross Hospital, Japan, 2.Department of Rehabilitation, Kyoto First Red Cross Hospital)

^○Katsura Suzuki, Nobuko Haneji (Life Design Laboratory 4 PD Japan, Japan)

^○Tomohito Ohashi (Department of Neurology, Nara Medical University, Japan)

^○Mikio Osawa¹, Mutsumi Iijima² (1.Botulinum Toxin Therapy Center for Neurology, Tokyo Clinic, Japan, 2.Department of Neurology, Tokyo Women's Medical University)

^○Aya Kumon¹, Midori Sagawa¹, Megumi Saruwatari¹, Noriko Kawashima², Kazuko Hasegawa¹ (1.Department of Neurology, National Hospital Organization, Sagamihara National Hospital, Japan, 2.Department of Neurology, Kawashima neurological clinic)

^○Yuki Yokokawa, Ikuko Aiba, Akira Inukai, Rina Hashimoto, Taiji Katayama, Yufuko Saito, Satoko Sakakibara, Misaki Sato, Masakuni Kenjo, Satoshi Okuda (Higashinagoya National Hospital Neurology, Japan)